Cancer research
Gain a more complete understanding of cancer biology
Cancer research solutions
In order to fulfill the promise of cancer precision medicine, a better understanding of cancer’s complex biology is needed. PacBio’s highly accurate long reads allow you to uncover novel isoforms, fusions, and structural variants with unmatched accuracy.
RNA ISOFORM + FUSION DISCOVERY
Cancer exhibits widespread RNA dysregulation. The Iso-Seq method uncovers the full repertoire of alternative splicing and fusion events.
STRUCTURAL VARIANT DETECTION
Structural variants (genomic differences ≥50 base pairs) are one of the main drivers of cancer. Most structural variants are too large to reliably discover with short-read DNA sequencing.
WHOLE GENOME SEQUENCING OF GERMLINE VARIANTS
Best-in-class variant calling for all variant types including single nucleotide variants (SNV), indels, and copy number variants (CNVs).
UNCOVER CANCER-SPECIFIC RNA ISOFORMS USING LONG-READ SEQUENCING
Alternative splicing (AS) results in the generation of multiple RNA isoforms from a single gene, greatly increasing both transcriptomic and proteomic diversity. AS controls which introns are removed from premRNAs and which exons are combined to form the final messenger RNA (mRNA).¹
Cancer research in action
Publication
A comprehensive long-read isoform analysis platform for breast cancer
Long-read RNA sequencing identifies novel biomarkers and drug targets in breast cancer.
Complex oncogene amplifications revealed
A detailed map of structural variations in breast cancer.
The RNA Isoform Landscape of Cancer
Learn how PacBio’s accurate long-read RNA sequencing provides true discovery power of cancer-related RNA isoforms and allows for the understanding of molecular mechanisms underlying cancer biology in this webinar.
Delivering new insights into cancer research
Meredith Ashby highlights the value of SMRT sequencing for deeper understanding of tumors at the genomic and transcriptomic level.
Explore
Did you know we have a comprehensive library of articles, reports, papers, and videos related to cancer research?
Shaping the future
Long reads reveal differences in drug response
Science
Research reveals that breast cancer patients with double mutations in cis have significantly increased P13K activity and downstream pathway activation and show enhanced sensitivity to PIK3CA targeted therapy.
THIS IS YOUR MOMENT
PacBio sequencers empower you to better understand the complex biology of cancer.
Reveal novel isoforms, fusions, and structural variants with unmatched accuracy.